Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
USE OUR INTELLIGENCE

Auto Draft
RESEARCH
December 14, 2022

Gut Microbes Can Boost the Motivation to Exercise

Some species of gut-dwelling bacteria activate nerves in the gut to promote the desire to…

USE OUR INTELLIGENCE December 14, 2022
A Potential Gamechanger in Beating Antimicrobial Resistance
RESEARCH
December 14, 2022

A Potential Gamechanger in Beating Antimicrobial Resistance

The Covid pandemic has revealed just how delicate our public health is in terms of…

USE OUR INTELLIGENCE December 14, 2022
Telemedicine Arrived in Brazil During the Pandemic and Came to Stay
TECHNOLOGY
December 14, 2022

Telemedicine Arrived in Brazil During the Pandemic and Came to Stay

A survey of 1,183 physicians in the Brazilian states of São Paulo and Maranhão shows…

USE OUR INTELLIGENCE December 14, 2022
UC San Diego Health Recognized for Health Equity in Care of Sickle Cell Crisis
DISEASES
December 13, 2022

UC San Diego Health Recognized for Health Equity in Care of Sickle Cell Crisis

UC San Diego Health has been awarded the prestigious 2022 California Association of Public Hospitals…

USE OUR INTELLIGENCE December 13, 2022
Boosting Accuracy, Reducing False Positives of PCR Covid-19 Tests
VIRUSES & VACCINES
December 13, 2022

Boosting Accuracy, Reducing False Positives of PCR Covid-19 Tests

PCR tests are the gold standard for COVID-19 diagnosis, but they’re not always accurate. False…

USE OUR INTELLIGENCE December 13, 2022
Frequently Using Digital Devices to Soothe Young Children May Backfire
RESEARCH
December 13, 2022

Frequently Using Digital Devices to Soothe Young Children May Backfire

It’s a scene many parents have experienced – just as they’re trying to cook dinner,…

USE OUR INTELLIGENCE December 13, 2022
Despite Soaring Overdose Rates, Americans Face Barriers to Treatment
PUBLIC HEALTH
December 13, 2022

Despite Soaring Overdose Rates, Americans Face Barriers to Treatment

Despite the fact that a record 107,000 Americans died of fatal drug overdoses last year,…

USE OUR INTELLIGENCE December 13, 2022
Paxlovid Effective in Reducing Covid-19 Hospitalization Among Vaccinated Adults 50 and Over
VIRUSES & VACCINES
December 13, 2022

Paxlovid Effective in Reducing Covid-19 Hospitalization Among Vaccinated Adults 50 and Over

The antiviral drug nirmatrelvir plus ritonavir (Paxlovid) was granted Emergency Use Authorization for treating COVID-19…

USE OUR INTELLIGENCE December 13, 2022
An Ounce of Prevention: Differences in HIV Prevention Activities Among Rural and Urban Physicians
VIRUSES & VACCINES
December 13, 2022

An Ounce of Prevention: Differences in HIV Prevention Activities Among Rural and Urban Physicians

HIV remains a major public health concern in the United States, with adolescents and young…

USE OUR INTELLIGENCE December 13, 2022
Researchers Uncover Factors Linked to Optimal Aging
PUBLIC HEALTH
December 13, 2022

Researchers Uncover Factors Linked to Optimal Aging

What are the keys to “successful” or optimal aging? A new study followed more than…

USE OUR INTELLIGENCE December 13, 2022
Older Posts Newer Posts
Latest Posts
  • Check for Copycat Bias in Medical AI
    TECHNOLOGY
    Check for Copycat Bias in Medical AI
    USE OUR INTELLIGENCE September 2, 2026
  • Brain Cancer: Immunotherapy First, Surgery Afterwards
    NEUROLOGY & MENTAL HEALTH, PHARMA & CLINICAL TRIALS
    Brain Cancer: Immunotherapy First, Surgery Afterwards
    USE OUR INTELLIGENCE September 2, 2026
  • Your Smartwatch Is Lying to You About How Many Calories You Burned, FIU Study Finds
    TECHNOLOGY
    Your Smartwatch Is Lying to You About How Many Calories You Burned, FIU Study Finds
    USE OUR INTELLIGENCE September 2, 2026
  • FDA Approves Breakthrough Pancreatic Cancer Drug – an Oncologist Explains How Daraxonrasib Nearly Doubles Survival
    PHARMA & CLINICAL TRIALS
    FDA Approves Breakthrough Pancreatic Cancer Drug – an Oncologist Explains How Daraxonrasib Nearly Doubles Survival
    USE OUR INTELLIGENCE September 2, 2026
  • Not All ‘Magic’ Mushrooms Are the Same
    PUBLIC HEALTH
    Not All ‘Magic’ Mushrooms Are the Same
    USE OUR INTELLIGENCE September 2, 2026
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

Global Health News Wire
  • HOME
  • GHNW Notes
  • PERMISSIONS AND POLICIES
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

I would like to receive critical industry news to my inbox.

Our site uses cookies. Learn more about our use of cookies: Cookie Policy

ACCEPT